| 摘要 |
Disclosed is the use of an agent that binds complement C5 in the manufacture of a medicament for treating or preventing a peripheral nerve disorder in a subject, wherein the agent that binds C5 is a protein comprising amino acids 19 to 168 of the amino acid sequence in Figure 2 or is a functional homologue or fragment of this protein. Further disclosed is a method of treating or preventing a peripheral nerve disorder in a non-human animal comprising administering to the non-human animal in need thereof an agent that binds complement C5, wherein the agent that binds C5 is a protein comprising amino acids 19 to 168 of the amino acid sequence in Figure 2 or is a functional homologue or fragment of this protein. |
